Genscript Biotech Announces Passing of INED Dr. Alphonse Galdes; Reconstitutes Board Committees

Bulletin Express

Yesterday

Genscript Biotech Corporation reported that independent non-executive director (INED) and Audit Committee member Dr. Alphonse Galdes passed away on 13 September 2026 (Hong Kong Time). Dr. Galdes had served on the Board since September 2024.

Effective 16 September 2026, the Board appointed INED Dr. Victor Shi to the Audit Committee. Concurrently, Dr. Shi stepped down from the Nomination Committee and the Strategy Committee.

Post-reconfiguration, the Board consists of nine directors—four executive and five independent. The Audit Committee now comprises three members: Chairman Mr. Andy Cheung, Mr. Ethan Pan and Dr. Victor Shi. The Nomination Committee consists of five members, and the Strategy Committee comprises three members.

The company stated that it continues to meet the minimum requirements for independent non-executive directors under Listing Rule 3.10(1) and for Audit Committee membership under Listing Rule 3.21.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/news/1150333914"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1150333914\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1150333914?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-16 17:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1150333914","market":"us","top_or_hot":-1,"title":"Genscript Biotech Announces Passing of INED Dr. Alphonse Galdes; Reconstitutes Board Committees","media":"Bulletin Express","content":"<p>Genscript Biotech Corporation reported that independent non-executive director (INED) and Audit Committee member Dr. Alphonse Galdes passed away on 13 September 2026 (Hong Kong Time). Dr. Galdes had served on the Board since September 2024.</p>\n<p>Effective 16 September 2026, the Board appointed INED Dr. Victor Shi to the Audit Committee. Concurrently, Dr. Shi stepped down from the Nomination Committee and the Strategy Committee.</p>\n<p>Post-reconfiguration, the Board consists of nine directors—four executive and five independent. The Audit Committee now comprises three members: Chairman Mr. Andy Cheung, Mr. Ethan Pan and Dr. Victor Shi. The Nomination Committee consists of five members, and the Strategy Committee comprises three members.</p>\n<p>The company stated that it continues to meet the minimum requirements for independent non-executive directors under Listing Rule 3.10(1) and for Audit Committee membership under Listing Rule 3.21.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Genscript Biotech Announces Passing of INED Dr. Alphonse Galdes; Reconstitutes Board Committees</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGenscript Biotech Announces Passing of INED Dr. Alphonse Galdes; Reconstitutes Board Committees\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-09-16 17:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Genscript Biotech Corporation reported that independent non-executive director (INED) and Audit Committee member Dr. Alphonse Galdes passed away on 13 September 2026 (Hong Kong Time). Dr. Galdes had served on the Board since September 2024.</p>\n<p>Effective 16 September 2026, the Board appointed INED Dr. Victor Shi to the Audit Committee. Concurrently, Dr. Shi stepped down from the Nomination Committee and the Strategy Committee.</p>\n<p>Post-reconfiguration, the Board consists of nine directors—four executive and five independent. The Audit Committee now comprises three members: Chairman Mr. Andy Cheung, Mr. Ethan Pan and Dr. Victor Shi. The Nomination Committee consists of five members, and the Strategy Committee comprises three members.</p>\n<p>The company stated that it continues to meet the minimum requirements for independent non-executive directors under Listing Rule 3.10(1) and for Audit Committee membership under Listing Rule 3.21.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01548","symbol_name":"金斯瑞生物科技","start_time":0,"source_url":"","article_id":"1150333914","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1150333914","pubTimestamp":1789549640,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Genscript Biotech Corporation reported that independent non-executive director (INED) and Audit Committee member Dr. Alphonse Galdes passed away on 13 September 2026 (Hong Kong Time). Dr. Galdes had...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01548":"金斯瑞生物科技"},"translate_title":"金斯瑞生物科技宣布独立非执行董事 Alphonse Galdes 博士去世；重组董事会委员会","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01548":1},"content_text":"Genscript Biotech Corporation reported that independent non-executive director (INED) and Audit Committee member Dr. Alphonse Galdes passed away on 13 September 2026 (Hong Kong Time). Dr. Galdes had served on the Board since September 2024.\nEffective 16 September 2026, the Board appointed INED Dr. Victor Shi to the Audit Committee. Concurrently, Dr. Shi stepped down from the Nomination Committee and the Strategy Committee.\nPost-reconfiguration, the Board consists of nine directors—four executive and five independent. The Audit Committee now comprises three members: Chairman Mr. Andy Cheung, Mr. Ethan Pan and Dr. Victor Shi. The Nomination Committee consists of five members, and the Strategy Committee comprises three members.\nThe company stated that it continues to meet the minimum requirements for independent non-executive directors under Listing Rule 3.10(1) and for Audit Committee membership under Listing Rule 3.21.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"executive,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}